Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MMA
MCID: MTH008
MIFTS: 47

Methylmalonic Acidemia (MMA)

Categories: Blood diseases, Endocrine diseases, Liver diseases, Metabolic diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Methylmalonic Acidemia

About this section

MalaCards integrated aliases for Methylmalonic Acidemia:

Name: Methylmalonic Acidemia 12 77 54 26 30 6 15
Methylmalonic Aciduria 12 26 38 30 56
Mma 54 26
Isolated Methylmalonic Acidemia 26
Acidemia, Methylmalonic 54

Classifications:

MalaCards categories:
Global: Rare diseases Metabolic diseases
Anatomical: Endocrine diseases Liver diseases Blood diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:14749
KEGG 38 H00174
Sources

Summaries for Methylmalonic Acidemia

About this section
NIH Rare Diseases : 54 Methylmalonic acidemia is an inherited condition in which the body is unable to process certain proteins and fats properly. Signs and symptoms usually appear in early infancy and vary from mild to life-threatening. Affected infants can experience vomiting, dehydration, weak muscle tone (hypotonia), developmental delay, lethargy, hepatomegaly, and failure to thrive. Long-term complications can include feeding problems, intellectual disability, chronic kidney disease, and pancreatitis. Without treatment, this condition can lead to coma and death in some cases.Mutations in the MUT, MMAA, MMAB, MMADHC, and MCEE genes cause methylmalonic acidemia. It is inherited in an autosomal recessive fashion. Methylmalonic acidemia is treated with a low-protein, high-calorie diet, certain medications, antibiotics and, in some cases, organ transplantation.

MalaCards based summary : Methylmalonic Acidemia, also known as methylmalonic aciduria, is related to methylmalonic acidemia with homocystinuria and vitamin b12-responsive methylmalonic acidemia. An important gene associated with Methylmalonic Acidemia is MMAA (Metabolism Of Cobalamin Associated A), and among its related pathways/superpathways are Valine, leucine and isoleucine degradation and Metabolism. The drugs Hydroxocobalamin and Methylcobalamin have been mentioned in the context of this disorder. Affiliated tissues include kidney, liver and pancreas.

Disease Ontology : 12 An organic acidemia that involves an accumulation of methylmalonic acid in the blood.

Genetics Home Reference : 26 Methylmalonic acidemia is an inherited disorder in which the body is unable to process certain proteins and fats (lipids) properly. The effects of methylmalonic acidemia, which usually appear in early infancy, vary from mild to life-threatening. Affected infants can experience vomiting, dehydration, weak muscle tone (hypotonia), developmental delay, excessive tiredness (lethargy), an enlarged liver (hepatomegaly), and failure to gain weight and grow at the expected rate (failure to thrive). Long-term complications can include feeding problems, intellectual disability, chronic kidney disease, and inflammation of the pancreas (pancreatitis). Without treatment, this disorder can lead to coma and death in some cases.

Wikipedia : 77 Methylmalonic acidemia (MMA), also called methylmalonic aciduria,[help 1] is an autosomal... more...

Sources

Related Diseases for Methylmalonic Acidemia

About this section

Diseases in the Methylmalonic Acidemia family:

Methylmalonic Acidemia Due to Transcobalamin Receptor Defect

Diseases related to Methylmalonic Acidemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 131)
# Related Disease Score Top Affiliating Genes
1 methylmalonic acidemia with homocystinuria 34.6 MMACHC MMADHC
2 vitamin b12-responsive methylmalonic acidemia 34.3 MMAA MTR
3 isolated methylmalonic acidemia 34.2 MMAB MMUT
4 methylmalonic aciduria, cblb type 33.5 MMAA MMAB MVK
5 methylmalonic aciduria and homocystinuria, cblc type 33.1 MMACHC MMD MTR
6 succinate-coa ligase deficiency 32.1 SUCLA2 SUCLG1
7 transcobalamin ii deficiency 31.5 LMBRD1 MMAA MMADHC MMD MMUT MTR
8 methylmalonic aciduria due to methylmalonyl-coa mutase deficiency 30.8 LMBRD1 MCEE MMAA MMAB MMACHC MMADHC
9 homocystinuria 30.6 LMBRD1 MMACHC MMADHC MTR
10 megaloblastic anemia 30.3 LMBRD1 MMADHC MTR
11 mevalonic aciduria 30.3 MMAB MVK
12 mitochondrial dna depletion syndrome 29.8 SUCLA2 SUCLG1
13 methylmalonic acidemia and homocysteinemia, cblx type 12.7
14 mitochondrial dna depletion syndrome, encephalomyopathic form with methylmalonic aciduria 12.6
15 methylmalonic acidemia due to transcobalamin receptor defect 12.5
16 methylmalonic aciduria and homocystinuria, cbld type 12.4
17 suclg1-related mitochondrial dna depletion syndrome, encephalomyopathic form with methylmalonic aciduria 12.4
18 methylmalonic aciduria microcephaly cataract 12.4
19 methylmalonic acidemia with homocystinuria type cblj 12.3
20 methylmalonic aciduria, cbla type 12.3
21 mitochondrial dna depletion syndrome 5 12.3
22 sucla2-related mitochondrial dna depletion syndrome, encephalomyopathic form with methylmalonic aciduria 12.2
23 homocystinuria without methylmalonic aciduria 12.2
24 methylmalonic aciduria and homocystinuria, cblf type 12.1
25 amyotrophy, monomelic 11.9
26 monoclonal mast cell activation syndrome 11.7
27 methylmalonic aciduria, transient, due to transcobalamin receptor defect 11.5
28 o'sullivan-mcleod syndrome 11.5
29 methylmalonyl-coa epimerase deficiency 11.4
30 striatonigral degeneration, infantile 11.4
31 mitochondrial dna depletion syndrome 9 11.4
32 methylmalonic aciduria and homocystinuria type cble 11.3
33 methylmalonic aciduria and homocystinuria type cblg 11.3
34 combined malonic and methylmalonic aciduria 11.2
35 methylmalonic aciduria and homocystinuria, cblj type 11.2
36 homocystinuria-megaloblastic anemia, cble complementation type 11.2
37 homocystinuria-megaloblastic anemia, cblg complementation type 11.2
38 mohr-tranebjaerg syndrome 11.2
39 methylmalonyl-coenzyme a mutase deficiency 11.2
40 propionic acidemia 10.5
41 diabetes mellitus, ketosis-prone 10.4
42 homocysteinemia 10.3
43 hyperglycemia 10.3
44 retinal degeneration 10.3
45 spasticity 10.2
46 hydrocephalus 10.2
47 renal tubular acidosis 10.2
48 pancytopenia 10.2
49 optic nerve disease 10.2
50 dystonia 10.2

Graphical network of the top 20 diseases related to Methylmalonic Acidemia:



Diseases related to Methylmalonic Acidemia
Sources

Symptoms & Phenotypes for Methylmalonic Acidemia

About this section
Sources

Drugs & Therapeutics for Methylmalonic Acidemia

About this section

Drugs for Methylmalonic Acidemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hydroxocobalamin Approved Phase 3,Phase 2 13422-51-0 11953898 15589840
2
Methylcobalamin Approved, Experimental, Investigational Phase 3,Phase 2 13422-55-4
3
Metronidazole Approved Phase 3 443-48-1 4173
4
Cyanocobalamin Approved, Nutraceutical Phase 3,Phase 2 68-19-9 44176380
5
Biotin Approved, Investigational, Nutraceutical Phase 3 58-85-5 171548
6
Cobalamin Experimental Phase 3,Phase 2 13408-78-1 6857388
7 Vitamin B 12 Phase 3,Phase 2
8 Vitamin B Complex Phase 3,Phase 2
9 Vitamins Phase 3,Phase 2
10 Vitamin B12 Phase 3,Phase 2
11 carnitine Phase 3
12 Vitamin B7 Phase 3
13
carbamide peroxide Approved Phase 2 124-43-6
14
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
15
Ornithine Approved, Nutraceutical Phase 2 3184-13-2, 70-26-8 6262
16
Glutamic Acid Approved, Nutraceutical Phase 2 56-86-0 33032
17 Vitamin B9 Phase 2
18 Folate Phase 2
19 Micronutrients Phase 2
20 Trace Elements Phase 2
21 Nutrients Phase 2
22 Hematinics Phase 2
23 Ubiquinone Phase 2
24 Antioxidants Phase 2

Interventional clinical trials:

(show all 11)
# Name Status NCT ID Phase Drugs
1 Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia Active, not recruiting NCT02426775 Phase 3 Carglumic Acid
2 EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment Completed NCT01793090 Phase 2 Epi-743
3 Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants Completed NCT01624311 Phase 2
4 Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia Recruiting NCT01599286 Phase 2 Carbaglu;Placebo;Standard of Care Treatment
5 Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia Not yet recruiting NCT03810690 Phase 1, Phase 2
6 Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia Terminated NCT01597440 Phase 2 N-carbamylglutamate
7 Ataluren for Nonsense Mutation Methylmalonic Acidemia Terminated NCT01141075 Phase 2 Ataluren (PTC124)
8 Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate Withdrawn NCT01341379 Phase 2 N-carbamylglutamate
9 Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study Unknown status NCT01289158
10 Clinical and Laboratory Study of Methylmalonic Acidemia Recruiting NCT00078078
11 "The MaP Study": Mapping the Patient Journey in MMA and PA Recruiting NCT03484767

Search NIH Clinical Center for Methylmalonic Acidemia

Sources

Genetic Tests for Methylmalonic Acidemia

About this section

Genetic tests related to Methylmalonic Acidemia:

# Genetic test Affiliating Genes
1 Methylmalonic Acidemia 30
2 Methylmalonic Aciduria 30
Sources

Anatomical Context for Methylmalonic Acidemia

About this section

MalaCards organs/tissues related to Methylmalonic Acidemia:

42
Kidney, Liver, Pancreas, Brain, Testes, Globus Pallidus, Bone Marrow
Sources

Publications for Methylmalonic Acidemia

About this section

Articles related to Methylmalonic Acidemia:

(show top 50) (show all 398)
# Title Authors Year
1
Combined malonic and methylmalonic aciduria due to ACSF3 mutations: Benign clinical course in an unselected cohort. ( 30740739 )
2019
2
The Value of 1H-MRS and MRI in Combined Methylmalonic Aciduria and Homocystinuria. ( 30839328 )
2019
3
Mutation analysis of genes related to methylmalonic acidemia: identification of eight novel mutations. ( 30712249 )
2019
4
Management of adult-onset methylmalonic acidemia with hypotonia and acute respiratory failure: A case report. ( 29924026 )
2018
5
Atypical adult-onset methylmalonic acidemia and homocystinuria presenting as hemolytic uremic syndrome. ( 29294253 )
2018
6
A male case with CDKL5-associated encephalopathy manifesting transient methylmalonic acidemia. ( 29510241 )
2018
7
Favorable course of previously undiagnosed Methylmalonic Aciduria with Homocystinuria (cblC type) presenting with pulmonary hypertension and aHUS in a young child: a case report. ( 30103768 )
2018
8
Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria. ( 30157807 )
2018
9
Hydrocephalus in cblC type methylmalonic acidemia. ( 30564975 )
2018
10
Shunt surgery for early-onset severe hydrocephalus in methylmalonic acidemia: report on two cases and review of the literature. ( 29488077 )
2018
11
Mild clinical features of isolated methylmalonic acidemia associated with a novel variant in the MMAA gene in two Chinese siblings. ( 29996803 )
2018
12
Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data. ( 30023298 )
2018
13
Spectrum of bone marrow pathology and hematological abnormalities in methylmalonic acidemia. ( 29330964 )
2018
14
Generation and characterization of two human iPSC lines from patients with methylmalonic acidemia cblB type. ( 29660608 )
2018
15
Methylmalonic acidemia: Current status and research priorities. ( 29862147 )
2018
16
Ammonia role in glial dysfunction in methylmalonic acidemia. ( 30008432 )
2018
17
Autozygosity mapping of methylmalonic acidemia associated genes by short tandem repeat markers facilitates the identification of five novel mutations in an Iranian patient cohort. ( 30022420 )
2018
18
Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes. ( 30080956 )
2018
19
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia. ( 30157442 )
2018
20
Combining newborn metabolic and DNA analysis for second-tier testing of methylmalonic acidemia. ( 30209273 )
2018
21
Elevated methylmalonic acidemia (MMA) screening markers in Hispanic and preterm newborns. ( 30448007 )
2018
22
FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia. ( 30518688 )
2018
23
Newborn Screening for Methylmalonic Acidemia in a Chinese Population: Molecular Genetic Confirmation and Genotype Phenotype Correlations. ( 30728829 )
2018
24
New perspectives for pharmacological chaperoning treatment in methylmalonic aciduria cblB type. ( 29197662 )
2018
25
Transcobalamin receptor defect: Identification of two new cases through positive newborn screening for propionic/methylmalonic aciduria and long-term outcome. ( 29663633 )
2018
26
Diagnostic dilemma of patients with methylmalonic aciduria: Experience from a tertiary care centre in Pakistan. ( 29808036 )
2018
27
New in vitro model derived from brain-specific Mut-/- mice confirms cerebral ammonium accumulation in methylmalonic aciduria. ( 29934063 )
2018
28
Acute Illness Protocol for Organic Acidemias: Methylmalonic Acidemia and Propionic Acidemia. ( 28141776 )
2017
29
Combined methylmalonic acidemia and homocysteinemia presenting predominantly with late-onset diffuse lung disease: a case series of four patients. ( 28327205 )
2017
30
Mutation Analyses in Selected Exons of the MUT Gene in Indian Patients with Methylmalonic Acidemia. ( 28811685 )
2017
31
Methylmalonic Acidemia with Novel MUT Gene Mutations. ( 29158924 )
2017
32
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia. ( 29262333 )
2017
33
Targeted exome sequencing for the identification of complementation groups in methylmalonic aciduria: A south Indian experience. ( 27591164 )
2017
34
Manic-depressive Psychosis as the Initial Symptom in Adult Siblings with Late-onset Combined Methylmalonic Aciduria and Homocystinemia, Cobalamin C Type. ( 28218226 )
2017
35
Corrigendum to "Next generation sequencing of patients with mut methylmalonic aciduria: Validation of somatic cell studies and identification of 16 novel mutations." [Mol. Genet. Metab. (Aug 2016); 118(4): 264-71]. ( 28284539 )
2017
36
Renal Involvement in Methylmalonic Aciduria. ( 29270502 )
2017
37
Development and Validation of a GC-FID Method for Diagnosis of Methylmalonic Acidemia. ( 27536704 )
2016
38
Improvement in the prognosis and development of patients with methylmalonic acidemia after living donor liver transplant. ( 27670840 )
2016
39
Pulmonary artery hypertension in methylmalonic acidemia. ( 27804229 )
2016
40
The proteome of methylmalonic acidemia (MMA): the elucidation of altered pathways in patient livers. ( 26672496 )
2016
41
Methylmalonic Acidemia Diagnosis by Laboratory Methods. ( 28070528 )
2016
42
Identification of a novel deletion in the MMAA gene in two Iranian siblings with vitamin B12-responsive methylmalonic acidemia. ( 28536607 )
2016
43
Perioperative management of living-donor liver transplantation for methylmalonic acidemia. ( 27221384 )
2016
44
Isolated methylmalonic acidemia with unusual presentation mimicking diabetic ketoacidosis. ( 26581066 )
2016
45
[Identification of two novel mutations of MUT gene in a Chinese family affected with isolated methylmalonic acidemia]. ( 27060300 )
2016
46
Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. ( 27748010 )
2016
47
Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia. ( 26790480 )
2016
48
Juvenile gout in methylmalonic acidemia. ( 26952825 )
2016
49
Isolated methylmalonic acidemia: a case report. ( 27492701 )
2016
50
Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia. ( 26979128 )
2016
Sources

Variations for Methylmalonic Acidemia

About this section

ClinVar genetic disease variations for Methylmalonic Acidemia:

6 (show top 50) (show all 532)
# Gene Variation Type Significance SNP ID Assembly Location
1 MMUT NM_000255.3(MMUT): c.393G> A (p.Gln131=) single nucleotide variant Conflicting interpretations of pathogenicity rs145682249 GRCh37 Chromosome 6, 49425764: 49425764
2 MMUT NM_000255.3(MMUT): c.393G> A (p.Gln131=) single nucleotide variant Conflicting interpretations of pathogenicity rs145682249 GRCh38 Chromosome 6, 49458051: 49458051
3 MMADHC NM_015702.2(MMADHC): c.453G> A (p.Gln151=) single nucleotide variant Benign rs11545261 GRCh38 Chromosome 2, 149576462: 149576462
4 MMADHC NM_015702.2(MMADHC): c.453G> A (p.Gln151=) single nucleotide variant Benign rs11545261 GRCh37 Chromosome 2, 150432976: 150432976
5 MMUT NM_000255.3(MMUT): c.982C> T (p.Leu328Phe) single nucleotide variant Pathogenic/Likely pathogenic rs796052002 GRCh37 Chromosome 6, 49421399: 49421399
6 MMUT NM_000255.3(MMUT): c.982C> T (p.Leu328Phe) single nucleotide variant Pathogenic/Likely pathogenic rs796052002 GRCh38 Chromosome 6, 49453686: 49453686
7 MMUT NM_000255.3(MMUT): c.711A> G (p.Pro237=) single nucleotide variant Conflicting interpretations of pathogenicity rs138085432 GRCh37 Chromosome 6, 49425446: 49425446
8 MMUT NM_000255.3(MMUT): c.711A> G (p.Pro237=) single nucleotide variant Conflicting interpretations of pathogenicity rs138085432 GRCh38 Chromosome 6, 49457733: 49457733
9 MMUT NM_000255.3(MMUT): c.572C> A (p.Ala191Glu) single nucleotide variant Pathogenic rs760782399 GRCh37 Chromosome 6, 49425585: 49425585
10 MMUT NM_000255.3(MMUT): c.572C> A (p.Ala191Glu) single nucleotide variant Pathogenic rs760782399 GRCh38 Chromosome 6, 49457872: 49457872
11 MMADHC NM_015702.2(MMADHC): c.617A> G (p.Asn206Ser) single nucleotide variant Conflicting interpretations of pathogenicity rs138607412 GRCh37 Chromosome 2, 150427678: 150427678
12 MMADHC NM_015702.2(MMADHC): c.617A> G (p.Asn206Ser) single nucleotide variant Conflicting interpretations of pathogenicity rs138607412 GRCh38 Chromosome 2, 149571164: 149571164
13 MMAA NM_172250.2(MMAA): c.64C> T (p.Arg22Ter) single nucleotide variant Pathogenic rs765799472 GRCh38 Chromosome 4, 145639203: 145639203
14 MMAA NM_172250.2(MMAA): c.64C> T (p.Arg22Ter) single nucleotide variant Pathogenic rs765799472 GRCh37 Chromosome 4, 146560355: 146560355
15 MMUT NM_000255.3(MMUT): c.2080C> T (p.Arg694Trp) single nucleotide variant Pathogenic rs777758903 GRCh38 Chromosome 6, 49435500: 49435500
16 MMUT NM_000255.3(MMUT): c.2080C> T (p.Arg694Trp) single nucleotide variant Pathogenic rs777758903 GRCh37 Chromosome 6, 49403213: 49403213
17 MMUT NM_000255.3(MMUT): c.1280G> A (p.Gly427Asp) single nucleotide variant Pathogenic rs753288303 GRCh38 Chromosome 6, 49451518: 49451518
18 MMUT NM_000255.3(MMUT): c.1280G> A (p.Gly427Asp) single nucleotide variant Pathogenic rs753288303 GRCh37 Chromosome 6, 49419231: 49419231
19 MMAB NM_052845.3(MMAB): c.197-1G> T single nucleotide variant Pathogenic rs763935916 GRCh38 Chromosome 12, 109568864: 109568864
20 MMAB NM_052845.3(MMAB): c.197-1G> T single nucleotide variant Pathogenic rs763935916 GRCh37 Chromosome 12, 110006669: 110006669
21 MMUT NM_000255.3(MMUT): c.655A> T (p.Asn219Tyr) single nucleotide variant Pathogenic rs121918256 GRCh37 Chromosome 6, 49425502: 49425502
22 MMUT NM_000255.3(MMUT): c.655A> T (p.Asn219Tyr) single nucleotide variant Pathogenic rs121918256 GRCh38 Chromosome 6, 49457789: 49457789
23 MMAB NM_052845.3(MMAB): c.556C> T (p.Arg186Trp) single nucleotide variant Pathogenic rs28941784 GRCh37 Chromosome 12, 109998873: 109998873
24 MMAB NM_052845.3(MMAB): c.556C> T (p.Arg186Trp) single nucleotide variant Pathogenic rs28941784 GRCh38 Chromosome 12, 109561068: 109561068
25 MMAA NM_172250.3(MMAA): c.433C> T (p.Arg145Ter) single nucleotide variant Pathogenic rs104893851 GRCh37 Chromosome 4, 146560724: 146560724
26 MMAA NM_172250.3(MMAA): c.433C> T (p.Arg145Ter) single nucleotide variant Pathogenic rs104893851 GRCh38 Chromosome 4, 145639572: 145639572
27 MMUT NM_000255.3(MMUT): c.1495G> A (p.Ala499Thr) single nucleotide variant Benign/Likely benign rs2229385 GRCh37 Chromosome 6, 49415448: 49415448
28 MMUT NM_000255.3(MMUT): c.1495G> A (p.Ala499Thr) single nucleotide variant Benign/Likely benign rs2229385 GRCh38 Chromosome 6, 49447735: 49447735
29 MMUT NM_000255.3(MMUT): c.1595G> A (p.Arg532His) single nucleotide variant Benign/Likely benign rs1141321 GRCh37 Chromosome 6, 49412433: 49412433
30 MMUT NM_000255.3(MMUT): c.1595G> A (p.Arg532His) single nucleotide variant Benign/Likely benign rs1141321 GRCh38 Chromosome 6, 49444720: 49444720
31 MMUT NM_000255.3(MMUT): c.1629C> T (p.Ser543=) single nucleotide variant Conflicting interpretations of pathogenicity rs150642856 GRCh37 Chromosome 6, 49412399: 49412399
32 MMUT NM_000255.3(MMUT): c.1629C> T (p.Ser543=) single nucleotide variant Conflicting interpretations of pathogenicity rs150642856 GRCh38 Chromosome 6, 49444686: 49444686
33 MMUT NM_000255.3(MMUT): c.2011A> G (p.Ile671Val) single nucleotide variant Benign rs8589 GRCh37 Chromosome 6, 49403282: 49403282
34 MMUT NM_000255.3(MMUT): c.2011A> G (p.Ile671Val) single nucleotide variant Benign rs8589 GRCh38 Chromosome 6, 49435569: 49435569
35 MMUT NM_000255.3(MMUT): c.636G> A (p.Lys212=) single nucleotide variant Benign rs2229384 GRCh37 Chromosome 6, 49425521: 49425521
36 MMUT NM_000255.3(MMUT): c.636G> A (p.Lys212=) single nucleotide variant Benign rs2229384 GRCh38 Chromosome 6, 49457808: 49457808
37 MMAB; MVK NM_052845.3(MMAB): c.288T> C (p.Ile96=) single nucleotide variant Benign/Likely benign rs62000414 GRCh37 Chromosome 12, 110006577: 110006577
38 MMAB; MVK NM_052845.3(MMAB): c.288T> C (p.Ile96=) single nucleotide variant Benign/Likely benign rs62000414 GRCh38 Chromosome 12, 109568772: 109568772
39 MMAB NM_052845.3(MMAB): c.716T> A (p.Met239Lys) single nucleotide variant Benign rs9593 GRCh37 Chromosome 12, 109994870: 109994870
40 MMAB NM_052845.3(MMAB): c.716T> A (p.Met239Lys) single nucleotide variant Benign rs9593 GRCh38 Chromosome 12, 109557065: 109557065
41 MMAA NM_172250.2(MMAA): c.1089G> C (p.Gln363His) single nucleotide variant Benign/Likely benign rs2270655 GRCh37 Chromosome 4, 146576418: 146576418
42 MMAA NM_172250.2(MMAA): c.1089G> C (p.Gln363His) single nucleotide variant Benign/Likely benign rs2270655 GRCh38 Chromosome 4, 145655266: 145655266
43 MMAB; MVK NM_000431.3(MVK): c.155G> A (p.Ser52Asn) single nucleotide variant Benign/Likely benign rs7957619 GRCh37 Chromosome 12, 110013879: 110013879
44 MMAB; MVK NM_000431.3(MVK): c.155G> A (p.Ser52Asn) single nucleotide variant Benign/Likely benign rs7957619 GRCh38 Chromosome 12, 109576074: 109576074
45 MCEE NM_032601.3(MCEE): c.227C> T (p.Ala76Val) single nucleotide variant Benign rs11541017 GRCh37 Chromosome 2, 71351487: 71351487
46 MCEE NM_032601.3(MCEE): c.227C> T (p.Ala76Val) single nucleotide variant Benign rs11541017 GRCh38 Chromosome 2, 71124357: 71124357
47 MCEE NM_032601.3(MCEE): c.311G> T (p.Arg104Leu) single nucleotide variant Benign/Likely benign rs6748672 GRCh37 Chromosome 2, 71351403: 71351403
48 MCEE NM_032601.3(MCEE): c.311G> T (p.Arg104Leu) single nucleotide variant Benign/Likely benign rs6748672 GRCh38 Chromosome 2, 71124273: 71124273
49 MMAA NM_172250.3(MMAA): c.-56A> G single nucleotide variant Benign/Likely benign rs4835011 GRCh37 Chromosome 4, 146560236: 146560236
50 MMAA NM_172250.3(MMAA): c.-56A> G single nucleotide variant Benign/Likely benign rs4835011 GRCh38 Chromosome 4, 145639084: 145639084
Sources

Expression for Methylmalonic Acidemia

About this section
Search GEO for disease gene expression data for Methylmalonic Acidemia.
Sources

Pathways for Methylmalonic Acidemia

About this section

Pathways related to Methylmalonic Acidemia according to KEGG:

38
# Name Kegg Source Accession
1 Valine, leucine and isoleucine degradation hsa00280

Pathways related to Methylmalonic Acidemia according to GeneCards Suite gene sharing:

(show all 15)
# Super pathways Score Top Affiliating Genes
1
Metabolism 67
Show member pathways
 13.81 GPD2 LMBRD1 MCEE MMAA MMAB MMACHC
2
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) 67
Show member pathways
 12.66 GPD2 MCEE MMAA MMUT PCCA
3
Metabolism of water-soluble vitamins and cofactors 67
Show member pathways
 12.47 LMBRD1 MMAA MMAB MMACHC MMADHC MMUT
4
Carbon metabolism 38
Show member pathways
 12.12 MCEE MMUT MTR PCCA SUCLA2 SUCLG1
5
Selenium Micronutrient Network 1
Show member pathways
 12.11 MCEE MMAB MMUT MTR
6
Valine, leucine and isoleucine degradation 38
Show member pathways
 11.76 MCEE MMUT PCCA
7
Diseases of metabolism 67
Show member pathways
 11.6 MMAA MMACHC MMADHC MMUT MTR PCCA
8
Mitochondrial Fatty Acid Beta-Oxidation 67
Show member pathways
 11.52 MCEE MMAA MMUT PCCA
9
Glyoxylate and dicarboxylate metabolism 38
11.09 MCEE MMUT PCCA
10
superpathway of methionine degradation 1
Show member pathways
 10.96 MCEE PCCA
11
Vitamin digestion and absorption 38
10.92 LMBRD1 MMACHC
12
Propanoate metabolism 38
10.86 MCEE MMUT PCCA SUCLA2 SUCLG1
13
Valproic Acid Pathway, Pharmacodynamics 62
Show member pathways
 10.85 SUCLA2 SUCLG1
14
Cobalamin (Cbl, vitamin B12) transport and metabolism 67
10.49 LMBRD1 MMAA MMAB MMACHC MMADHC MMUT
15
Defective MUT causes methylmalonic aciduria mut type 67
Show member pathways
 10.06 MMAA MMUT
Sources

GO Terms for Methylmalonic Acidemia

About this section

Cellular components related to Methylmalonic Acidemia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mitochondrion GO:0005739 9.61 GPD2 MCEE MMAA MMAB MMADHC MMUT
2 mitochondrial matrix GO:0005759 9.17 MCEE MMAA MMAB MMUT PCCA SUCLA2

Biological processes related to Methylmalonic Acidemia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 tricarboxylic acid cycle GO:0006099 9.32 SUCLA2 SUCLG1
2 succinate metabolic process GO:0006105 9.26 SUCLA2 SUCLG1
3 cobalamin metabolic process GO:0009235 9.17 LMBRD1 MMAA MMAB MMACHC MMADHC MMUT
4 succinyl-CoA metabolic process GO:0006104 9.16 SUCLA2 SUCLG1
5 cobalamin biosynthetic process GO:0009236 9.13 MMAA MMAB MMACHC

Molecular functions related to Methylmalonic Acidemia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ligase activity GO:0016874 9.33 PCCA SUCLA2 SUCLG1
2 cobalamin binding GO:0031419 9.02 LMBRD1 MMAB MMACHC MMUT MTR
3 succinate-CoA ligase (ADP-forming) activity GO:0004775 8.96 SUCLA2 SUCLG1
Sources

Sources for Methylmalonic Acidemia

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....